October 24, 2011Date Released: 24 October 2011
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
The Case CCC and the Meredith A. Cowden Foundation are bringing a national educational conference on Graft vs. Host Disease (GvHD) to Cleveland on Friday, November 4, 7:30 am to 5 pm, at the Renaissance Cleveland Hotel. The conference will unite leading specialists in hematology, oncology, bone marrow transplantation and immunology from more than a dozen of the nation's top cancer research centers and educational institutions to present information on cutting-edge research and treatments.
Following bone marrow transplantation, an estimated 60 percent of all leukemia and other blood cancer patients experience GvHD, making this topic extremely relevant to our Center. Please make every effort to register and attend this conference.
CASE CCC IN THE NEWS
Research Ties Dermatology Workforce Balance and Melanoma Outcomes
ABC News.com - Radiotherapy Packs a Powerful Anti-Cancer Punch
MARK YOUR CALENDARSCancer Center Seminar Series: Autophagy, Tumor Dormancy and Taxane Sensitivity in Human Ovarian Cancer
Friday, October 28
Please join us Friday, October 28 at the next Cancer Center Seminar Series featuring Robert C. Bast, Jr, MD, who will present Autophagy, Tumor Dormancy and Taxane Sensitivity in Human Ovarian Cancer.
Dr. Bast is Vice President for Translational Research at the UT MD Anderson Cancer Center. His office facilitates translation of new strategies, drugs and devices from the laboratory to the clinic, as well as the movement of human material and data from the clinic to laboratory. A former director of the Duke Comprehensive Cancer Center, Dr. Bast has a history of research at other distinguished institutions such as Johns Hopkins Hospital, the NCI, Harvard, and Dana-Farber Cancer Institute. He is also a member of the Parent Committee for Cancer Center Reviews for the NCI.
Dr. Bast is best known for developing the OC125 monoclonal antibody that led to the production of the CA125 radioimmunoassay. Serum CA125 levels have provided the first generally useful serum biomarker for ovarian cancer that is now used worldwide for monitoring the course of patients with this disease. CA125 is currently being evaluated as one component of a screening strategy for early detection of ovarian cancer. His early studies focused on the use of immunostimulants and monoclonal antibodies for cancer therapy. Over the last 20 years, his group has pioneered in defining molecular alterations in ovarian and breast cancers that might serve as targets for therapy as well as diagnosis. His most recent studies have focused on the identification of ARHI, a novel ras-related imprinted tumor suppressor gene that can induce autophagy and tumor dormancy, providing the first inducible model for tumor dormancy in ovarian cancer.Federal Research Priorities and Budgets for FY12
Do you wish you knew where federal agencies are headed and how to align your funding requests to their priorities and direction? Join your colleagues October 31-November 2 forthis webinar and hear directly from personnel at the NIH, NSF, National Endowment for the Humanities, Office of Naval Research, Army Medical and Materiel Command, National Aeronautics and Space Administration, and the Departments of Agriculture, Education and Energy as they share agency direction and funding priorities for the coming year.
Registration is not necessary. Stop in the Sears Library Building, Room 670 and view the agency presentations relevant to your research initiatives.The Cancer Genome Atlas Program: Comprehensive Cancer Genomics Data on 5,000+ Cases Across 24 Cancer Subtypes
The NCI Office of Cancer Centers presents the next webinar in its Learning Series, The Cancer Genome Atlas Program: Comprehensive Cancer Genomics Data on 5,000+ Cases Across 24 Cancer Subtypes, on Tuesday, November 1 from 2-3:30 pm. This presentation will address The Cancer Genome Atlas (TCGA) program, which aims to complete the comprehensive genomic characterization of more than 11,000 tumors by the end of 2014.
The featured speakers are: Kenna Shaw, PhD, Deputy Director of The Cancer Genome Atlas Program Office, who will discuss the current projects and discoveries of the TCGA program, and Jill Barnholtz-Sloan, PhD, Associate Professor at Case Western Reserve University/University Hospitals, who will provide information about her work for the TCGA program.
Pre-registration is required.Coulter Legacy Lecture
The Coulter Legacy Lecture will be held Tuesday, November 1 at 10:45 am in the Wolstein Research Building Auditorium. Sue Van, President & Chief Executive Officer of the Coulter Foundation, will give a lecture on the legacy of Wallace H. Coulter and his influence on entrepreneurism, and his path as a serial innovator and entrepreneur.
Mr. Coulter founded Coulter Corp. and continued to lead this global diagnostics company during its entire 40-year history. He revolutionized the practice of hematology and laboratory medicine, and pioneered the fields of flow cytometry and monoclonal antibodies. Please plan on attending what promises to be a fascinating lecture.NCRM Annual Scientific Retreat
The National Center for Regenerative Medicine (NCRM) Annual Scientific Retreat will be Monday, November 14 from 8 am-4:30 pm in Dively 202. Anyone within the CWRU community with an interest in regenerative medicine is encouraged to attend, including faculty, researchers, postdocs, graduate and undergraduate students, lab staff, and clinicians. The day will include a scientific poster session. Cash prizes will be awarded for top posters submitted by graduate students and postdocs. Please send poster title and abstract to Susan Halloway. There is no fee to attend, butregistration is required.
FUNDING OPPORTUNITIES2012 NIH Director's Transformative Research Awards
The NIH has announced the funding opportunity for the 2012 NIH Director's Transformative Research Awards. The awards are aimed at "exceptionally innovative, high risk, original and/or unconventional research".
LOI Deadline: December 12
The L'Oréal USA Fellowships For Women In Science is a national awards program that annually recognizes and rewards five US-based women postdoctoral researchers at the beginning of their scientific careers who are pursuing careers in the life and physical/material sciences, as well as mathematics, engineering and computer science. The recipients of this fellowship program participate in a week of events that include an awards ceremony, professional development workshops, media training and networking opportunities.
Deadline: December 15Lymphatic Research Foundation Postdoctoral Fellowship Awards Program
The Lymphatic Research Foundation (LRF) Postdoctoral Fellowship Program is designed to support postdoctoral scientists in academic, medical or research institutions throughout the world. The awards will support investigators who have recently received their doctorates, a critical point in career development when young scientists choose their lifelong research focus. The goal of the Fellowship Program is to expand and strengthen the pool of outstanding junior investigators in the field of lymphatic research.
Deadline: January 10, 2012CTSC Annual Pilot Funding Competition
The Clinical and Translational Science Collaborative (CTSC) of CWRU and the Case Coulter Translational Research Partnership (CCTRP) is accepting letters of intent for 2012 CTSC Annual Pilot Grant Funding. The grant will fund up to $50,000 to support innovative translational research projects focused upon the invention, preclinical development and/or first in man studies of novel therapeutic agents, biomedical devices and diagnostics designed to address unmet clinical needs.
Investigators in the basic science and clinical departments at CWRU, Cleveland Clinic, MetroHealth Medical Center, UH and the Louis Stokes Cleveland VA Medical Center are eligible. The PI is required to be a faculty member from one of the five CTSC partner institutions and eligible to be a PI for an NIH grant.
Mandatory LOI Deadline: January 15
ANNOUNCEMENTSLazarus Honored By Two Organizations
Congratulations to Dr. Hillard Lazarus, who was named Man of the Year by the Northern Ohio Leukemia and Lymphoma Society.
Dr. Lazarus was also recently recognized by his alma mater, Carnegie Mellon, with the 2011 Alumni Distinguished Achievement Award.CWRU Interdisciplinary Alliance Investment Grant Awardees
The following projects led by Cancer Center members were selected to receive CWRU Interdisciplinary Alliance Investment Grants:
The proposals were scored on overall quality and innovation, extent of interdisciplinary research and/or education, significance relative to the university's mission, vision and core values and feasibility and sustainability.
NCI CANCER BULLETINOctober 18, 2011
**All events are open to anyone interested in attending
David Satcher Lecture Series
Pathology Research Seminar Series
Tumor Microenvironment and Metastasis Focus Group Meeting
Cancer Biology Special Seminar canceled
Hematology and Oncology Division Research Conference
Immunology Invited Speaker Seminar Series
Nuclear Receptor Signaling and Hormone Responsive Cancers Focus Group
Molecular and Microbiology Seminar
Hematology/Oncology Fellows Conference
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Graft Versus Host Disease Conference
ADDITIONAL UPCOMING SEMINARS & EVENTS
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED OPPORTUNITIES
AACR-FNAB Fellows Grant for Translational Pancreatic Cancer Research
AACR–Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award
NIH BULLETIN – Notices and Funding Opportunities
National Cancer Institute Program Project (P01) Applications (PAR-12-005)
Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21)(PA-11-074)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.